I'll take a shot at a trifecta news release for Monday or Tuesday:
1) update on K trial, Cohort 7 now with IRB and safety committee for cohort 8, no DLT observed yet
2) Prurisol update for start of Phase 1 bridge study
3) Orphan drug approval, headline
I'll settle for 1 of those, but putting 20 down, on the nose, 3 times.